HS
MDCO

HighVista Strategies’s Medicines Co MDCO Stock Holding History

HighVista Strategies’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-90,409
Closed -$4.52M – 154
2019
Q3 		$4.52M Hold
90,409
– – 3.09% 4
2019
Q2 		$3.3M Sell
90,409
-143,931
-61% -$4.7M 1.69% 10
2019
Q1 		$6.55M Hold
234,340
– – 5.34% 2
2018
Q4 		$4.49M Sell
234,340
-33,900
-13% -$789K 3.88% 4
2018
Q3 		$8.02M Hold
268,240
– – 3.74% 6
2018
Q2 		$9.84M Hold
268,240
– – 4.44% 5
2018
Q1 		$8.84M Hold
268,240
– – 3.77% 8
2017
Q4 		$7.33M Hold
268,240
– – 2.04% 12
2017
Q3 		$9.94M Hold
268,240
– – 2.26% 12
2017
Q2 		$10.2M Hold
268,240
– – 2.33% 11
2017
Q1 		$13.1M Hold
268,240
– – 2.94% 11
2016
Q4 		$9.1M Hold
268,240
– – 1.79% 16
2016
Q3 		$10.1M Buy
268,240
+65,040
+32% +$2.45M 1.88% 13
2016
Q2 		$6.83M Buy
+203,200
New +$7.16M 1.31% 17

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

HighVista Strategies's MDCO Position: Q4 2019 in Review

HighVista Strategies sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 90,409 shares — an estimated $4.52M sold.

HighVista Strategies first reported a position in MDCO in Q2 2016 and held it in 14 quarters. The position peaked at $13.1M in Q1 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • HighVista Strategies reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • HighVista Strategies sold 90,409 Medicines Co shares in Q4 2019, an estimated $4.52M.
  • HighVista Strategies first reported a position in Medicines Co in Q2 2016 and held it in 14 quarters.
  • HighVista Strategies's Medicines Co position peaked at $13.1M in Q1 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on HighVista Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.